✦ LIBER ✦

Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation

✍ Scribed by C. Kahl; M. Leithäuser; D. Wolff; B. Steiner; G. Hartung; J. Casper; M. Freund

Publisher: Springer
Year: 2002
Tongue: English
Weight: 74 KB
Volume: 81
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-002-0556-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

✍ Min Kyoung Kim; Shin Kim; Sung Sook Lee; Sun Jin Sym; Dae Ho Lee; Seongsoo Jang; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 167 KB

Successful treatment of advanced periphe

Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation

✍ T. Sato; K. Kogawa; S. Iyama; D. Kobayashi; Y. Sato; K. Kuribayashi; K. Takada; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 731 KB

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases

✍ J. Tsuchiyama; K. Imajo; T. Yoshino; N. Nanba; A. Toyota; C. Yoshida; K. Fujii; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 119 KB

High-dose chemotherapy with hematopoieti

High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma

✍ Christopher J. Campen; Rebecca L. Tombleson; Myke R. Green 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 222 KB

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

✍ M. Engelhardt; R. Zeiser; G. Ihorst; J. Finke; C. I. Müller 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 512 KB